Abstract
Acute myeloid leukemia is a disease that affects predominantly older patients, with a median age at diagnosis of 68. Overall prognosis is poor, but novel therapies that have emerged in recent years offer hope that outcomes can improve. In this comprehensive presentation, speakers covered a broad array of topics, including diagnostic workup, risk stratification, and novel therapeutic agents, and walked listeners through three illustrative case presentations.
